BioSalma AB

Based in Sweden, BioSalma AB specializes in high-quality nutritional supplements aimed at enhancing athletic performance and overall health, offering a diverse range of products tailored to specific dietary needs. BioSalma AB, founded in 2013 in Stockholm, Sweden, focuses on nutritional supplements tailored for health-conscious consumers and athletes. The company has undergone strategic development to strengthen its market position, but no significant pivots or changes in operations have been reported. The founder's background details are not provided, and there are no mentions of subsidiaries or parent companies.

In total, BioSalma has completed 1 deal, with the most recent financial transaction involving Vision Healthcare N. V. , which acquired BioSalma AB, although the financial terms were not disclosed. BioSalma AB specializes in nutritional supplements, focusing on enhancing athletic performance and overall health.

Their core product offerings include omega-3 fatty acids, vitamins, and probiotics, designed to address various health needs such as energy enhancement, skin health, and digestive support. The company emphasizes the use of high-quality raw materials sourced globally, with production primarily based in Norway, alongside facilities in Sweden, Germany, and Poland. BioSalma's products cater to health-conscious consumers, athletes, and individuals seeking dietary supplements, which are sold across various geographical markets in Europe and potentially beyond. With a range of vegan and non-vegan products, including chewable omega-3 and specific formulations for hair, skin, and nails, BioSalma addresses diverse dietary preferences and health goals.

BioSalma generates revenue primarily through the direct sale of its nutritional supplements to consumers and retailers. The company employs a business-to-consumer model, allowing individual customers to purchase products directly from their website, and a business-to-business approach by partnering with retailers and wholesalers for broader distribution. Their product lineup includes specialty items such as vegan omega-3 and various vitamin complexes, catering to both casual users and dedicated athletes. BioSalma's revenue structure reflects the demand for high-quality health solutions, ensuring a steady flow of transactions from repeat customers and partnerships with health-focused retailers.

The acquisition of BioSalma AB by Vision Healthcare N. V. is expected to enhance its services and strengthen its market presence. While specific upcoming products and targeted market expansions have not been detailed, the acquisition allows for the potential development of new offerings and increased distribution capabilities in the health supplement sector.